Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China flag China · Delayed Price · Currency is CNY
2.630
-0.090 (-3.31%)
Nov 17, 2026, 3:00 PM CST

SHA:603363 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
9,1348,4478,73119,43221,58118,013
Other Revenue
27.7927.7931.4125.2131.9325.56
9,1628,4758,76319,45821,61318,038
Revenue Growth
12.11%-3.29%-54.96%-9.97%19.82%56.62%
Cost of Revenue
9,0237,9568,36720,76720,95618,209
Gross Profit
139.34518.85395.6-1,309657.28-170.49
Selling, General & Admin
593.84529.291,1291,0711,073944.98
Research & Development
53.8849.7554.47148.86161.67113.88
Other Operating Expenses
53.6826.716.0524.625.76-2.41
Operating Expenses
698.82628.751,2451,2911,2851,101
Operating Income
-559.49-109.9-849.59-2,600-628.17-1,272
Interest Expense
-43.08-143.19-650.95-549.99-505.83-418.77
Interest & Investment Income
131.15522.132,0435.195.943.76
Currency Exchange Gain (Loss)
0.080.08-0.1-1.41-6.85-0.34
Other Non Operating Income (Expenses)
-341.18-157.45-53.81-52.18-75.77-20.85
EBT Excluding Unusual Items
-812.52111.67488.56-3,198-1,211-1,708
Impairment of Goodwill
-27.47-27.47-35.39-34.66-36.51-12.14
Gain (Loss) on Sale of Investments
-3.49-3.98-30.32-4.07-119.76-68.86
Gain (Loss) on Sale of Assets
-15.58-3.225.59-49.74-9.41-25.09
Asset Writedown
-15.75-15.75-98.51-424.3-2.76-7.63
Other Unusual Items
66.944.09-245.4329.3784.1-
Pretax Income
-807.91105.3484.49-3,682-1,295-1,822
Income Tax Expense
55.9715.9321.487.05-69.2129.34
Earnings From Continuing Operations
-863.8889.4163.09-3,769-1,226-1,851
Minority Interest in Earnings
135.8-11.79516.25117.86187.46331.05
Net Income
-728.0777.62579.35-3,651-1,038-1,520
Net Income to Common
-728.0777.62579.35-3,651-1,038-1,520
Net Income Growth
--86.60%----
Shares Outstanding (Basic)
2,6062,587865867775650
Shares Outstanding (Diluted)
2,6062,587865867775650
Shares Change
21.12%199.23%-0.29%11.91%19.30%3.15%
EPS (Basic)
-0.280.030.67-4.21-1.34-2.34
EPS (Diluted)
-0.280.030.67-4.21-1.34-2.34
EPS Growth
--95.52%----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-47.77-79.95-379.46472.23-835.31-2,184
Free Cash Flow Per Share
-0.02-0.03-0.440.55-1.08-3.36
Gross Margin
1.52%6.12%4.52%-6.73%3.04%-0.95%
Operating Margin
-6.11%-1.30%-9.70%-13.36%-2.91%-7.05%
Profit Margin
-7.95%0.92%6.61%-18.76%-4.80%-8.43%
Free Cash Flow Margin
-0.52%-0.94%-4.33%2.43%-3.86%-12.11%
EBITDA
-295.48298.69-248.22-1,776232.72-574.94
EBITDA Margin
-3.23%3.52%-2.83%-9.13%1.08%-3.19%
D&A For EBITDA
264.01408.59601.37823.53860.9696.72
EBIT
-559.49-109.9-849.59-2,600-628.17-1,272
EBIT Margin
-6.11%-1.30%-9.70%-13.36%-2.91%-7.05%
Effective Tax Rate
-15.12%25.33%---
Revenue as Reported
2,1408,4758,76319,45821,61318,038